Formative Evaluation of the Acceptance of HIV Prevention Artificial Intelligence Chatbots By Men Who Have Sex With Men in Malaysia: Focus Group Study.

HIV prevention MSM artificial intelligence chatbot implementation science mHealth design men who have sex with men mobile health design mobile phone unified theory of acceptance and use of technology

Journal

JMIR formative research
ISSN: 2561-326X
Titre abrégé: JMIR Form Res
Pays: Canada
ID NLM: 101726394

Informations de publication

Date de publication:
06 Oct 2022
Historique:
received: 19 08 2022
accepted: 19 09 2022
revised: 17 09 2022
entrez: 6 10 2022
pubmed: 7 10 2022
medline: 7 10 2022
Statut: epublish

Résumé

Mobile technologies are being increasingly developed to support the practice of medicine, nursing, and public health, including HIV testing and prevention. Chatbots using artificial intelligence (AI) are novel mobile health strategies that can promote HIV testing and prevention among men who have sex with men (MSM) in Malaysia, a hard-to-reach population at elevated risk of HIV, yet little is known about the features that are important to this key population. The aim of this study was to identify the barriers to and facilitators of Malaysian MSM's acceptance of an AI chatbot designed to assist in HIV testing and prevention in relation to its perceived benefits, limitations, and preferred features among potential users. We conducted 5 structured web-based focus group interviews with 31 MSM in Malaysia between July 2021 and September 2021. The interviews were first recorded, transcribed, coded, and thematically analyzed using NVivo (version 9; QSR International). Subsequently, the unified theory of acceptance and use of technology was used to guide data analysis to map emerging themes related to the barriers to and facilitators of chatbot acceptance onto its 4 domains: performance expectancy, effort expectancy, facilitating conditions, and social influence. Multiple barriers and facilitators influencing MSM's acceptance of an AI chatbot were identified for each domain. Performance expectancy (ie, the perceived usefulness of the AI chatbot) was influenced by MSM's concerns about the AI chatbot's ability to deliver accurate information, its effectiveness in information dissemination and problem-solving, and its ability to provide emotional support and raise health awareness. Convenience, cost, and technical errors influenced the AI chatbot's effort expectancy (ie, the perceived ease of use). Efficient linkage to health care professionals and HIV self-testing was reported as a facilitating condition of MSM's receptiveness to using an AI chatbot to access HIV testing. Participants stated that social influence (ie, sociopolitical climate) factors influencing the acceptance of mobile technology that addressed HIV in Malaysia included privacy concerns, pervasive stigma against homosexuality, and the criminalization of same-sex sexual behaviors. Key design strategies that could enhance MSM's acceptance of an HIV prevention AI chatbot included an anonymous user setting; embedding the chatbot in MSM-friendly web-based platforms; and providing user-guiding questions and options related to HIV testing, prevention, and treatment. This study provides important insights into key features and potential implementation strategies central to designing an AI chatbot as a culturally sensitive digital health tool to prevent stigmatized health conditions in vulnerable and systematically marginalized populations. Such features not only are crucial to designing effective user-centered and culturally situated mobile health interventions for MSM in Malaysia but also illuminate the importance of incorporating social stigma considerations into health technology implementation strategies.

Sections du résumé

BACKGROUND BACKGROUND
Mobile technologies are being increasingly developed to support the practice of medicine, nursing, and public health, including HIV testing and prevention. Chatbots using artificial intelligence (AI) are novel mobile health strategies that can promote HIV testing and prevention among men who have sex with men (MSM) in Malaysia, a hard-to-reach population at elevated risk of HIV, yet little is known about the features that are important to this key population.
OBJECTIVE OBJECTIVE
The aim of this study was to identify the barriers to and facilitators of Malaysian MSM's acceptance of an AI chatbot designed to assist in HIV testing and prevention in relation to its perceived benefits, limitations, and preferred features among potential users.
METHODS METHODS
We conducted 5 structured web-based focus group interviews with 31 MSM in Malaysia between July 2021 and September 2021. The interviews were first recorded, transcribed, coded, and thematically analyzed using NVivo (version 9; QSR International). Subsequently, the unified theory of acceptance and use of technology was used to guide data analysis to map emerging themes related to the barriers to and facilitators of chatbot acceptance onto its 4 domains: performance expectancy, effort expectancy, facilitating conditions, and social influence.
RESULTS RESULTS
Multiple barriers and facilitators influencing MSM's acceptance of an AI chatbot were identified for each domain. Performance expectancy (ie, the perceived usefulness of the AI chatbot) was influenced by MSM's concerns about the AI chatbot's ability to deliver accurate information, its effectiveness in information dissemination and problem-solving, and its ability to provide emotional support and raise health awareness. Convenience, cost, and technical errors influenced the AI chatbot's effort expectancy (ie, the perceived ease of use). Efficient linkage to health care professionals and HIV self-testing was reported as a facilitating condition of MSM's receptiveness to using an AI chatbot to access HIV testing. Participants stated that social influence (ie, sociopolitical climate) factors influencing the acceptance of mobile technology that addressed HIV in Malaysia included privacy concerns, pervasive stigma against homosexuality, and the criminalization of same-sex sexual behaviors. Key design strategies that could enhance MSM's acceptance of an HIV prevention AI chatbot included an anonymous user setting; embedding the chatbot in MSM-friendly web-based platforms; and providing user-guiding questions and options related to HIV testing, prevention, and treatment.
CONCLUSIONS CONCLUSIONS
This study provides important insights into key features and potential implementation strategies central to designing an AI chatbot as a culturally sensitive digital health tool to prevent stigmatized health conditions in vulnerable and systematically marginalized populations. Such features not only are crucial to designing effective user-centered and culturally situated mobile health interventions for MSM in Malaysia but also illuminate the importance of incorporating social stigma considerations into health technology implementation strategies.

Identifiants

pubmed: 36201390
pii: v6i10e42055
doi: 10.2196/42055
pmc: PMC9585446
doi:

Types de publication

Journal Article

Langues

eng

Pagination

e42055

Subventions

Organisme : FIC NIH HHS
ID : R33 TW011665
Pays : United States
Organisme : FIC NIH HHS
ID : R21 TW011663
Pays : United States
Organisme : NIAID NIH HHS
ID : R21 AI152927
Pays : United States
Organisme : FIC NIH HHS
ID : R33 TW011663
Pays : United States
Organisme : NIDA NIH HHS
ID : K01 DA051346
Pays : United States
Organisme : FIC NIH HHS
ID : R21 TW011665
Pays : United States
Organisme : NCATS NIH HHS
ID : UL1 TR001863
Pays : United States

Informations de copyright

©Mary L Peng, Jeffrey A Wickersham, Frederick L Altice, Roman Shrestha, Iskandar Azwa, Xin Zhou, Mohd Akbar Ab Halim, Wan Mohd Ikhtiaruddin, Vincent Tee, Adeeba Kamarulzaman, Zhao Ni. Originally published in JMIR Formative Research (https://formative.jmir.org), 06.10.2022.

Références

Front Nutr. 2022 Jun 23;9:870775
pubmed: 35811989
MMWR Morb Mortal Wkly Rep. 2017 Aug 11;66(31):830-832
pubmed: 28796758
JMIR Cancer. 2021 Nov 29;7(4):e27850
pubmed: 34847056
JMIR Public Health Surveill. 2018 Feb 08;4(1):e15
pubmed: 29422452
BMC Public Health. 2021 Oct 29;21(1):1959
pubmed: 34715833
Drug Alcohol Depend. 2015 Jun 1;151:31-7
pubmed: 25865907
J Am Med Inform Assoc. 2022 Apr 13;29(5):1000-1010
pubmed: 35137107
Implement Sci. 2009 Aug 07;4:50
pubmed: 19664226
Int J Drug Policy. 2019 Jun;68:54-61
pubmed: 30999243
J Adv Nurs. 2016 Dec;72(12):2954-2965
pubmed: 27221824
Adm Policy Ment Health. 2011 Mar;38(2):65-76
pubmed: 20957426
JMIR Public Health Surveill. 2016 Aug 04;2(2):e33
pubmed: 27493067
Int J Med Inform. 2009 Jun;78(6):404-16
pubmed: 19196548
Expert Rev Med Devices. 2021 Dec;18(sup1):37-49
pubmed: 34872429
AIDS Behav. 2016 Jan;20(1):98-106
pubmed: 26324078
Top Antivir Med. 2019 Apr;27(1):8-25
pubmed: 31136999
Singapore Med J. 2008 Mar;49(3):256-60; quiz 261
pubmed: 18363011
Med Health Care Philos. 2022 Mar;25(1):61-71
pubmed: 34480711
J Subst Abuse. 2001;13(1-2):185-200
pubmed: 11547619
Appl Clin Inform. 2018 Apr;9(2):238-247
pubmed: 29618139
Qual Health Res. 2018 Nov;28(13):2094-2101
pubmed: 30043686
JMIR Mhealth Uhealth. 2021 Nov 9;9(11):e26424
pubmed: 34751667
JMIR Cancer. 2019 May 02;5(1):e12856
pubmed: 31045505
J Int AIDS Soc. 2017 Aug 2;20(1):21899
pubmed: 28782336
J Med Internet Res. 2020 Sep 14;22(9):e20701
pubmed: 32924957
Open AIDS J. 2017 Nov 21;11:119-132
pubmed: 29290888
BMJ Glob Health. 2021 Aug;6(9):
pubmed: 34475026
J Am Med Inform Assoc. 2018 Sep 1;25(9):1248-1258
pubmed: 30010941
Front Commun (Lausanne). 2020 Nov;5:
pubmed: 33644162
PLoS One. 2011;6(12):e28760
pubmed: 22194906

Auteurs

Mary L Peng (ML)

Social and Behavioral Sciences Department, Yale School of Public Health, New Haven, CT, United States.

Jeffrey A Wickersham (JA)

Section of Infectious Disease, Department of Internal Medicine, Yale School of Medicine, New Haven, CT, United States.
Center for Interdisciplinary Research on AIDS (CIRA), Yale University, New Haven, CT, United States.
Centre of Excellence for Research in AIDS (CERiA), Faculty of Medicine, University of Malaya, Kuala Lumpur, Malaysia.

Frederick L Altice (FL)

Section of Infectious Disease, Department of Internal Medicine, Yale School of Medicine, New Haven, CT, United States.
Center for Interdisciplinary Research on AIDS (CIRA), Yale University, New Haven, CT, United States.
Centre of Excellence for Research in AIDS (CERiA), Faculty of Medicine, University of Malaya, Kuala Lumpur, Malaysia.
Division of Epidemiology of Microbial Diseases, Yale School of Public Health, New Haven, CT, United States.

Roman Shrestha (R)

Center for Interdisciplinary Research on AIDS (CIRA), Yale University, New Haven, CT, United States.
Centre of Excellence for Research in AIDS (CERiA), Faculty of Medicine, University of Malaya, Kuala Lumpur, Malaysia.
Department of Allied Health Sciences, University of Connecticut, Storrs, CT, United States.

Iskandar Azwa (I)

Centre of Excellence for Research in AIDS (CERiA), Faculty of Medicine, University of Malaya, Kuala Lumpur, Malaysia.
Department of Medicine, Infectious Disease Unit, Faculty of Medicine, Kuala Lumpur, Malaysia.

Xin Zhou (X)

Section of Infectious Disease, Department of Internal Medicine, Yale School of Medicine, New Haven, CT, United States.

Mohd Akbar Ab Halim (MAA)

Centre of Excellence for Research in AIDS (CERiA), Faculty of Medicine, University of Malaya, Kuala Lumpur, Malaysia.

Wan Mohd Ikhtiaruddin (WM)

Centre of Excellence for Research in AIDS (CERiA), Faculty of Medicine, University of Malaya, Kuala Lumpur, Malaysia.

Vincent Tee (V)

Centre of Excellence for Research in AIDS (CERiA), Faculty of Medicine, University of Malaya, Kuala Lumpur, Malaysia.

Adeeba Kamarulzaman (A)

Section of Infectious Disease, Department of Internal Medicine, Yale School of Medicine, New Haven, CT, United States.
Centre of Excellence for Research in AIDS (CERiA), Faculty of Medicine, University of Malaya, Kuala Lumpur, Malaysia.
Department of Medicine, Infectious Disease Unit, Faculty of Medicine, Kuala Lumpur, Malaysia.

Zhao Ni (Z)

Center for Interdisciplinary Research on AIDS (CIRA), Yale University, New Haven, CT, United States.
School of Nursing, Yale University, New Haven, CT, United States.

Classifications MeSH